TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 17.07%-814.67M | ---- | 4.71%-982.36M | ---- | -305.11%-1.03B | ---- | -25.82%502.62M | ---- | 5.17%677.55M |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | -28.25%-30.22M | ---- | 69.99%-23.56M | ---- | 0.07%-78.52M | ---- | -48.46%-78.57M | ---- | -55.50%-52.92M |
Impairment and provisions: | ---- | -69.90%351.97M | ---- | 78.09%1.17B | ---- | 835.84%656.55M | ---- | 44.57%70.16M | ---- | 90.22%48.53M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | --6.8M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -69.72%351.97M | ---- | 77.05%1.16B | ---- | 835.84%656.55M | ---- | 44.57%70.16M | ---- | 90.22%48.53M |
Depreciation and amortization: | ---- | -10.32%742.23M | ---- | 24.77%827.64M | ---- | 12.26%663.33M | ---- | 13.50%590.88M | ---- | 10.35%520.59M |
-Amortization of intangible assets | ---- | -15.55%475.75M | ---- | 31.28%563.34M | ---- | 14.75%429.12M | ---- | 15.92%373.95M | ---- | 4.92%322.59M |
Financial expense | ---- | -28.60%951.24M | ---- | -12.98%1.33B | ---- | 21.59%1.53B | ---- | 54.64%1.26B | ---- | 40.73%814.17M |
Special items | ---- | 84.19%-191.13M | ---- | -635.73%-1.21B | ---- | -236.68%-164.33M | ---- | -3,525.26%-48.81M | ---- | 113.52%1.43M |
Operating profit before the change of operating capital | ---- | -9.39%1.01B | ---- | -29.35%1.11B | ---- | -31.30%1.58B | ---- | 14.23%2.3B | ---- | 19.93%2.01B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 124.84%3.62M | ---- | -89.09%-14.57M | ---- | -58.83%-7.71M | ---- | -247.24%-4.85M | ---- | 97.37%-1.4M |
Accounts receivable (increase)decrease | ---- | 32.47%-896.41M | ---- | -17.12%-1.33B | ---- | 57.51%-1.13B | ---- | 31.43%-2.67B | ---- | -2.49%-3.89B |
Accounts payable increase (decrease) | ---- | 1,495.75%726.31M | ---- | 78.89%-52.04M | ---- | 22.50%-246.49M | ---- | -152.17%-318.06M | ---- | -59.62%609.7M |
prepayments (increase)decrease | ---- | -79.84%29.49M | ---- | 2,132.52%146.28M | ---- | 102.48%6.55M | ---- | -21.99%-264.09M | ---- | -169.87%-216.48M |
Special items for working capital changes | ---- | -132.65%-328.5M | ---- | 155.89%1.01B | ---- | 31.84%-1.8B | ---- | -71.52%-2.64B | ---- | 26.14%-1.54B |
Cash from business operations | 171.93%257.14M | -37.66%543.92M | -83.41%94.56M | 154.38%872.44M | 147.33%569.87M | 55.44%-1.6B | 47.48%-1.2B | -18.88%-3.6B | -28.46%-2.29B | -24.20%-3.03B |
Other taxs | 52.75%-33.34M | 16.22%-146.57M | 29.01%-70.55M | -269.36%-174.94M | -13.73%-99.38M | 66.84%-47.36M | -25.93%-87.39M | 15.33%-142.81M | 9.59%-69.39M | -63.22%-168.67M |
Interest paid - operating | 19.33%-199.59M | 58.95%-448.67M | 18.00%-247.4M | 6.60%-1.09B | 61.46%-301.71M | 16.22%-1.17B | -21.89%-782.84M | -32.79%-1.4B | -41.79%-642.24M | -41.61%-1.05B |
Net cash from operations | 110.84%24.22M | 87.02%-51.32M | -232.36%-223.39M | 85.99%-395.4M | 108.14%168.78M | 45.10%-2.82B | 30.95%-2.07B | -20.96%-5.14B | -29.81%-3B | -29.37%-4.25B |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | -46.05%36.01M | ---- | --66.73M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | -60.38%-87.25M | 49.24%-134.16M | 55.45%-54.4M | -32.77%-264.3M | 32.69%-122.13M | 61.62%-199.07M | 42.06%-181.45M | 35.52%-518.65M | 8.04%-313.18M | -157.59%-804.32M |
Sale of subsidiaries | 21.64%280.21M | -16.31%322.09M | --230.36M | 257.72%384.89M | ---- | -71.32%107.59M | ---- | 2,360.49%375.2M | ---- | --15.25M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.46%-137.18M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 89.47%-40M | 80.20%-40M | ---380M |
Other items in the investment business | 231.76%12.26M | -29.02%37.25M | -447.16%-9.3M | 2,720.98%52.47M | -56.11%2.68M | -154.24%-2M | -97.13%6.11M | -85.29%3.69M | 1,624.24%212.82M | 40.55%25.09M |
Net cash from investment operations | 3.36%241.22M | 30.12%225.18M | 295.39%233.39M | 285.12%173.06M | 31.88%-119.45M | 48.00%-93.48M | -24.93%-175.35M | 85.97%-179.76M | 79.04%-140.36M | -171.84%-1.28B |
Net cash before financing | 2,554.15%265.44M | 178.19%173.86M | -79.73%10M | 92.37%-222.34M | 102.19%49.33M | 45.20%-2.92B | 28.46%-2.25B | 3.81%-5.32B | -5.38%-3.14B | -47.24%-5.53B |
Cash flow from financing activities | ||||||||||
New borrowing | -96.51%47.63M | -62.89%1.94B | -24.26%1.37B | -68.56%5.23B | -79.34%1.8B | -14.44%16.64B | -12.19%8.73B | 48.96%19.44B | 68.18%9.94B | 36.30%13.05B |
Refund | 67.22%-468.02M | 61.78%-1.83B | 33.71%-1.43B | 70.07%-4.78B | 75.99%-2.15B | -20.67%-15.96B | -71.27%-8.97B | -58.29%-13.22B | -62.16%-5.24B | -29.41%-8.35B |
Dividends paid - financing | ---- | ---- | ---- | 69.03%-42.3M | -63.22%-36.96M | 62.69%-136.58M | 83.33%-22.64M | -21.04%-366.04M | -61.74%-135.86M | -14.71%-302.4M |
Absorb investment income | -80.35%2M | 39.89%15.49M | 81.14%10.18M | 112.48%11.07M | 274.67%5.62M | -99.39%5.21M | -99.56%1.5M | 2,748.58%857.4M | 2,153.70%338.28M | -84.95%30.1M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.2B | ---- |
Other items of the financing business | 54.87%-17.73M | 57.69%-5.53M | -110.51%-39.29M | -101.19%-13.06M | -75.97%373.92M | 150.64%1.1B | 7,364.44%1.56B | -260.35%-2.16B | -102.15%-21.42M | --1.35B |
Net cash from financing operations | -380.77%-436.13M | -69.40%125.52M | -1,091.89%-90.72M | -75.07%410.18M | -100.59%-7.61M | -63.83%1.65B | -51.75%1.3B | -21.26%4.55B | -25.59%2.69B | 88.90%5.78B |
Effect of rate | -242.41%-3.39M | 83.80%-2.29M | 1,405.70%2.38M | -2,108.11%-14.12M | 116.14%158K | 575.00%703K | -366.76%-979K | -102.16%-148K | -87.58%367K | -53.71%6.85M |
Net Cash | -111.47%-170.69M | 59.38%299.38M | -293.47%-80.71M | 114.79%187.84M | 104.38%41.72M | -64.80%-1.27B | -108.51%-953.08M | -411.69%-770.6M | -172.81%-457.1M | 135.45%247.23M |
Begining period cash | 49.34%899.24M | 40.55%602.15M | 40.55%602.15M | -74.76%428.43M | -74.76%428.43M | -31.22%1.7B | -31.22%1.7B | 11.47%2.47B | 11.47%2.47B | -23.56%2.21B |
Cash at the end | 38.44%725.17M | 49.34%899.24M | 11.38%523.82M | 40.55%602.15M | -36.76%470.3M | -74.76%428.43M | -63.03%743.63M | -31.22%1.7B | -29.29%2.01B | 11.47%2.47B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Limited | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Limited | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Limited | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.